Cargando…
Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology
Prevalence of type 2 diabetes increased from 2.5% of the US population in 1990 to 10.5% in 2018. This creates a major public health problem, due to increases in long-term complications of diabetes, including neuropathy, retinopathy, nephropathy, skin ulcers, amputations, and atherosclerotic cardiova...
Autores principales: | Greenway, Frank, Loveridge, Brian, Grimes, Richard M., Tucker, Tori R., Alexander, Michael, Hepford, Scott A., Fontenot, Justin, Nobles-James, Candi, Wilson, Carol, Starr, Adam M., Abdelsaid, Mohammed, Lewis, Stanley T., Lakey, Jonathan R. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836751/ https://www.ncbi.nlm.nih.gov/pubmed/35163806 http://dx.doi.org/10.3390/ijms23031884 |
Ejemplares similares
-
A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality
por: Lewis, Stanley T., et al.
Publicado: (2023) -
Insulin receptor endocytosis in the pathophysiology of insulin resistance
por: Hall, Catherine, et al.
Publicado: (2020) -
Resensitizing AMPA receptors
por: Short, Ben
Publicado: (2019) -
Physiological Role of ATPase for GABA(A) Receptor Resensitization
por: Menzikov, Sergey A., et al.
Publicado: (2022) -
Resensitization in suspected penicillin allergy
por: Doña, Inmaculada, et al.
Publicado: (2022)